Enhancement of tacrolimus productivity in Streptomyces tsukubaensis by the use of novel precursors for biosynthesis

Enzyme and Microbial Technology

Volumn 51, Issue 6-7, 2012, Pages 388-395

  Turło, Jadwiga ^a   Gajzlerska, Wanda ^a   Klimaszewska, Marzenna ^a   Król, Marek ^a   Dawidowski, Maciej ^a   Gutkowska, Bozenna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

NAD; Piperidine carboxylic acid; Streptomyces tsukubaensis; Tacrolimus; Vitamin B3

Indexed keywords

CULTURE GROWTH; CULTURE MEDIUM; DYNAMICS SIMULATION; FERMENTATION MEDIUM; GROWTH PROMOTERS; MECHANISM OF ACTION; NAD; NICOTINAMIDE ADENINE DINUCLEOTIDES; NICOTINIC ACID; NOVEL PRECURSORS; OPTIMUM CONCENTRATION; PICOLINIC ACID; PIPECOLIC ACID; STREPTOMYCES TSUKUBAENSIS; TACROLIMUS; VITAMIN B;

NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID; PICOLINIC ACID; PIPECOLIC ACID; TACROLIMUS;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SYNTHESIS; FERMENTATION MEDIUM; HYPOTHESIS; NONHUMAN; PRECURSOR; PRODUCTIVITY; STIMULATION; STREPTOMYCES TSUKUBAENSIS;

BIOTECHNOLOGY; CULTURE MEDIA; FERMENTATION; KINETICS; NAD; NADP; NIACIN; NIACINAMIDE; PICOLINIC ACIDS; STREPTOMYCES; TACROLIMUS;

STREPTOMYCES TSUKUBAENSIS;

EID: 84867213160     PISSN: 01410229     EISSN: 18790909     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2012.08.008     Document Type: Article

References (34)

1. Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., et al. FK-506a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. Journal of Antibiotics 1987, 9:1249-1255.
2. Spencer C.M., Goa K.L., Gillis J.C. Tacrolimus: an update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997, 54(6):925-975.
3. Husain S., Singh N. The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials. Clinical Infectious Diseases 2002, 35:53-61.
4. Allison A.C. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000, 47:63-83.
5. Drake L., Prendergast M., Maher R., Breneman D., Korman N., Satoi Y., et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. Journal of the American Academy of Dermatology 2001, 44(1):65-72.
6. Graziani E.I. Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs. Natural Products Reports 2009, 26:602-609.
7. Pirsch J.D., Miller J., Deierhoi M.H., Yincenti F., Filo R.S. A comparison of tacrolimus (FK-506) and cyclosporine for immunosuppresion after cadaveric renal transplantation. FK506 kidney transplant study group. Transplantation 1997, 63(7):977-983.
8. Jiang H., Kobayashi M. Differences between cyclosporin A and tacrolimus in organ transplantation. Transplantation Proceedings 1999, 31:1978-1980.
9. Kelly D.A., Jara P., Rodeck B., Reding R., Bernard O., Burdelski M., et al. Tacrolimus dual therapy versus cyclosporin-microemulsion triple therapy in pediatric liver transplantation. Results from multicentre randomized trial. American Journal of Transplantation 2002, 2:351-359.
10. Okuhara M, Tanaka H, Goto T, Kino T, Hatanaka H. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same. US patent 4,894,366; 1990.
11. Singh B.P. Regulation of tacrolimus production by altering primary source of carbons and amino acids. Letters in Applied Microbiology 2009, 49(2):254-259.
12. Vaid S. A novel fermentation fed batch process for producing the immunosuppressant Tacrolimus (FK-506), using the mutant microorganism Streptomyces sp. utilizing vegetative oil as sole source of carbon in production medium. US patent 2007/0142424 A1; 2007.
13. Nakatsuka M., Ragan J.A., Sammakia T., Smith D., Uehling D., Schreiber S.L. Total synthesis of FK506 and an FKBP probe reagent, [C(8),C(9)-13C2]-FK506. Journal of the American Chemical Society 1990, 112(14):5583-5601.
14. Ireland R.E., Gleason J.L., Gegnas L.D., Highsmith T.K. A total synthesis of FK-506(1). Journal of Organic Chemistry 1996, 61(20):6856-6872.
15. Motamedi H., Shafiee A. The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK-506. European Journal of Biochemistry 1998, 256:528-534.
16. Gregory M.A., Hong H., Lill R.E., Gaisser S., Petkovic H., Low L., et al. Elucidation rapamycin biosynthesis of gene product function. Organic Biomolecular Chemistry 2006, 4:3565-3568.
17. Goranovic D., Kosec G., Mrak P., Fujs S., Horvat J., Kuscer E., et al. Origin of the alkyl group in FK506 biosynthesis. Journal of Biological Chemistry 2010, 285(19):14292-14300.
18. Lowden P.A., Wilkinson B., Bohm G.A., Handa S., Floss H.G., Leadlay P.F., et al. True nature of the starter unit for the rapamycin polyketide synthase. Angewandte Chemie - International Edition 2001, 40:777-779.
19. Gatto G.J., McLoughlin S.M., Kelleher N.L., Walsh C.T. Elucidating the substrate specificity and condensation domain activity of FkbP, the FK520 pipecolate-incorporating enzyme. Biochemistry 2005, 44:5993-6002.
20. Kato Y., Bai L., Xue Q., Revill W.P., Yu T.W., Floss H.G. Functional expression of genes involved in the biosynthesis of the novel polyketide chain extension unit, methoxymalonyl-acyl carrier protein, and engineered biosynthesis of 2-desmethyl-2-methoxy-6-deoxyerythronolide B. Journal of the American Chemical Society 2002, 124:5268-5269.
21. 3: from metabolism to therapies. Journal of Pharmacology and Experimental Therapeutics 2008, 324:883-893.
22. Turło J., Gutkowska B., Gajzlerska W. Submerged cultivation of Streptomyces tsukubaensis in media composed of waste products of food industry. Acta Poloniae Pharmaceutica 2006, 63(5):463-465.
23. Namiki Y., Kihara N., Koda S., Hane K., Yasuda T. Tautomeric phenomenon of potent immunosuppressant (FK506) in solution. I. Isolation and structure determination of tautomeric compounds. Journal of Antibiotics 1993, 46(7):1149-1155.
24. Akashi T., Nefuji T., Yoshida M., Hosoda Quantitive determination of tautomeric FK-506 by reversed-phase liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 1996, 14:339-346.
25. Nishikawa T., Hasumi H., Suzuki S., Kubo H., Ohtani H. Kinetic analysis of molecular interconversion of immunosuppressant FK506 by high-performance liquid chromatography. Pharmaceutical Research 1993, 10(12):1785-1789.
26. Sporty J., Kabir M.M., Turteltaub K.W., Ognibene T., Lin S.-J., Bench G. Single sample extraction protocol for the quantification of NAD and NADH redox states in Saccharomyces cerevisiae. Journal of Separation Science 2008, 31(18):3202-3211.
27. Jones D.P. Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography. Journal of Chromatography 1981, 225:446-449.
28. Grose J.H., Bergthorsson U., Roth J.R. Regulation of NAD synthesis by the trifunctional NadR protein of Salmonella enterica. Journal of Bacteriology 2005, 187(8):2774-2782.
29. Foster J.W., Moat A.G. Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiological Reviews 1980, 44:83-105.
30. Begley T.P., Kinsland C., Mehl R., Osterman A., Dorrestein P. The biosynthesis of nicotinamide adenine dinucleotides in bacteria. Vitamins and Hormones 2001, 61:103-119.
31. Gazzaniga F., Stebbins R., Chang S.Z., McPeek M.A., Brenner C. Microbial NAD metabolism: lessons from comparative genomics. Microbiology and Molecular Biology Reviews 2009, 73(3):529-541.
32. Foster J.W., Kinney D.M., Moat A.G. Pyridine nucleotyde cycle of Salmonella typhimurium: regulation of nicotinic acid phosphoribosyltransferase and nicotinamide deamidase. Journal of Bacteriology 1979, 138(3):957-961.
33. Gholson R.K., Kori J. Enzyme repression in the regulation of nicotinamide adenine dinucleotide biosynthesis in Bacillus subtilis. Journal of Biological Chemistry 1964, 239:2399-2400.
34. Imsande J. A comparative study of the regulation of pyridine nucleotide formation. Biochimica et Biophysica Acta 1964, 82:445-453.